Astrazeneca India company information, Employees & Contact Information

UK industry body finds AstraZeneca in breach of code over Symbicort marketing Reuters

AstraZeneca | Pharmaceuticals, Vaccines, & Facts Britannica

UK industry body finds AstraZeneca in breach of code over Symbicort marketing Yahoo

Consolidating Novavax transfers Maryland HQ lease to AstraZeneca in $60M deal Fierce Pharma

Novavax shrinking Montgomery County footprint, transferring manufacturing building to AstraZeneca The Business Journals

Administration reaches deal with AstraZeneca on lowering drug costs American Hospital Association

News | Novavax to transfer lease at Maryland property to AstraZeneca in money-saving move CoStar

Novavax Transfers Maryland Facility to AstraZeneca in $60 Million Deal citybiz

AstraZeneca’s New Study: Impact of AZD0780 on Metformin Pharmacokinetics TipRanks

AstraZeneca to build its largest-ever manufacturing facility in Virginia, creating hundreds of jobs Virginia Mercury

AstraZeneca, In A Buy Zone, Makes A Big Breast Cancer Splash Investor's Business Daily

Trump reaches deal with AstraZeneca to lower U.S. drug prices CNBC

Trump cuts pricing deal with AstraZeneca Axios

Trump announces deal with AstraZeneca aimed at lowering drug prices CNN

Trump reveals prescription drug deal with pharmaceutical giant AstraZeneca Al Jazeera

AstraZeneca, Daiichi’s Datroway excels in hard-to-treat breast cancer BioPharma Dive

AstraZeneca to list shares in New York while keeping London listing statnews.com

Lt. Governor Miller and Secretaries Rai and Coker Celebrate Major Biotech Investment by AstraZeneca in Rockville Office of Governor Wes Moore (.gov)

Novavax assigns Gaithersburg, Md. site to AstraZeneca (AZN) Seeking Alpha

AstraZeneca signs up to $555 million AI deal with Algen to develop therapies Reuters

AstraZeneca kicks off construction of $4.5B API plant in Virginia Fierce Pharma

AstraZeneca unveils expanded manufacturing facility in Texas Business Wire

Cell therapy biotech shares first clinical data for in vivo CAR-T that attracted $1B AstraZeneca acquisition Fierce Biotech

Pipeline power keeps AstraZeneca in rude health Proactive Investors

Shaping the Future of CVRM at ESC 2025 AstraZeneca

AstraZeneca agrees to lower drug prices for Medicaid under Trump administration deal ABC News - Breaking News, Latest News and Videos

Summit, AstraZeneca in talks over $15 billion cancer drug licensing deal, Bloomberg News reports Reuters

AstraZeneca Makes Another AI Deal With $555M Algen Alliance BioSpace

AstraZeneca’s at-home flu vaccine is a breakthrough that could pave the way for others PharmaVoice

AstraZeneca, Daiichi drug extends survival in hard-to-treat breast cancer BioPharma Dive

AstraZeneca to showcase latest research on comprehensive portfolio and pipeline aimed at transforming respiratory diseases at ATS 2025 AstraZeneca US

Anas Younes Has Been Appointed Chief Medical Officer at AstraZeneca Oncodaily

SAPHNELO self-administration TULIP-SC Phase III trial meets primary endpoint in patients with systemic lupus erythematosus based on an interim analysis AstraZeneca US

AstraZeneca Opens $300 Million Cell Therapy Manufacturing Facility in Montgomery County Montgomery County Maryland (.gov)

ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab granted Priority Review in the US as 1st-line treatment for patients with HER2-positive metastatic breast cancer AstraZeneca US

Trump unveils deal for AstraZeneca to cut Medicaid drug prices and join "TrumpRx" site CBS News

Va. backs big pharma deals for AstraZeneca in Albemarle, Eli Lilly in Goochland Richmond Times-Dispatch

FibroGen Completes Sale of FibroGen China to AstraZeneca for Approximately $220 Million Yahoo Finance

Pfizer-Arvinas breast cancer drug tops AstraZeneca's in delaying progression Reuters

AstraZeneca signs $555mn AI deal to identify immunology targets Financial Times

AstraZeneca Suspends $270M UK Commitment Months After Scrapping Vaccine Facility BioSpace

Delaware’s AstraZeneca site misses out on $50B investment Delaware Business Times

Fact Check: No, AstraZeneca doesn't mean 'a road to death' in Latin Yahoo

AstraZeneca announces $50 billion US manufacturing investment, matching its big pharma peers Yahoo Finance

AstraZeneca in $5B China-based AI research pact with CSPC FirstWord Pharma

AstraZeneca is Hiring Diagnostic Strategy Senior Director Oncodaily

TAGRISSO® (osimertinib) plus chemotherapy demonstrated a median overall survival of nearly four years, the longest benefit ever reported in a global Phase III trial in EGFR-mutated advanced lung cancer AstraZeneca US

J&J Passes AstraZeneca in Blockbuster Cancer Race — For Now Bloomberg.com

AstraZeneca quietly discontinues COVID-19 preventive in the US Chemical & Engineering News

Söderenergi partners with AstraZeneca on carbon removal Bioenergy Insight

Drugmaker AstraZeneca shifts more production to US amid Trump tariffs The Guardian

AstraZeneca adds ‘in vivo’ cell therapy capabilities with EsoBiotech deal BioPharma Dive

AstraZeneca's eco-friendly version of smoker's lung inhaler gets EU panel backing Reuters

Appeals Court Rejects AstraZeneca’s Challenge to Medicare Drug Price Negotiation Program Mintz

Announcing the 2024 Power of Us Award winners AstraZeneca US

AstraZeneca, Cellectis targeted in patent lawsuit over gene-editing technology Reuters

University of Michigan sues AstraZeneca, targeting 'master strains' used in FluMist Fierce Pharma

Comparison of SARS-CoV-2 immune responses following vaccination with Comirnaty (Pfizer) and Vaxzevria (AstraZeneca) in healthy individuals with or without prior SARS-CoV-2 infection Frontiers

TAGRISSO® (osimertinib) plus chemotherapy demonstrated statistically significant and clinically meaningful improvement in overall survival in EGFR-mutated advanced lung cancer AstraZeneca US

AstraZeneca in talks with Summit for over $15 billion license deal The Pharma Letter

Glenn Youngkin: AstraZeneca has Chosen the Commonwealth for Its Largest Investment in the World Oncodaily

AstraZeneca's Experimental Therapy Stumbles In Late-Stage Study For Rare Protein Deposit Condition Yahoo Finance

AstraZeneca pauses £200m Cambridge investment BBC

AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D Business Wire

AstraZeneca Commits $50B More to U.S. Manufacturing, R&D Projects Genetic Engineering and Biotechnology News

AstraZeneca to invest $50 billion in United States facilities upi.com

AstraZeneca goes in vivo, penning $1B deal for Belgian off-the-shelf cell therapy biotech Fierce Biotech

FibroGen sells China unit to AstraZeneca for $160m Pharmaceutical Technology

AstraZeneca gears up for FDA filing after sharing details of baxdrostat's hypertension success Fierce Biotech

Clear The Way – Don’t Jump the Gun: English Court of Appeal grants an Interim Injunction to AstraZeneca in Glenmark Dapagliflozin Case Wolters Kluwer

AstraZeneca takes $181M hit in Syntimmune shareholder lawsuit on top of previous $130M award Fierce Pharma

AstraZeneca Plans To Invest $50 Billion In America citybiz

Norah Shire Invited ASCO 2025 Attendees to Connect with AstraZeneca on Advancing Oncology Care Oncodaily

IMFINZI® (durvalumab) regimen demonstrated statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasive bladder cancer in POTOMAC Phase III trial AstraZeneca US

ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival vs. THP as 1st-line therapy for patients with HER2-positive metastatic breast cance AstraZeneca US

AstraZeneca quietly exits neuroscience BioPharma Dive

Driving innovation through partnership at AstraZeneca, with Nikhil Mutyal pharmaphorum

AstraZeneca deepens China presence with FibroGen deal BioPharma Dive

Harbour BioMed Enters into Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies PR Newswire

AstraZeneca: Government hits back in funding row with pharmaceutical giant BBC

IMFINZI® (durvalumab)-based regimen demonstrated statistically significant and clinically meaningful improvement in event-free survival in resectable early-stage gastric and gastroesophageal junction cancers AstraZeneca US

Big Pharma Showdown: Novartis vs. AstraZeneca in Q1 2025 Profits and Emissions Cuts CarbonCredits.com

AstraZeneca's big bet on Asia: $10B in deals amid controversy Labiotech.eu

Big pharma firms have paused nearly £2bn in UK investments this year | Pharmaceuticals industry The Guardian

Summit, AstraZeneca in talks over $15 billion cancer drug licensing deal, Bloomberg News reports By Reuters Investing.com

AstraZeneca unveils $300M Rockville investment, a boost for MoCo amid federal cuts The Business Journals

AstraZeneca Racks Up AI Partners, Seeking To Stop Cancer at All Stages BioSpace

AstraZeneca’s $1.3B bet on CinCor’s blood pressure med appears to pay off with phase 3 win Fierce Biotech

New study results reinforce TAGRISSO® (osimertinib) as the backbone therapy for EGFR-mutated lung cancer across stages and settings AstraZeneca US

AstraZeneca pauses £200m investment in Cambridge research site The Guardian

AstraZeneca bounces back from scandal in China Financial Times

AstraZeneca Makes $5.3B AI Bet With China’s CSPC for Chronic Disease Pills BioSpace

Covington & Burling counsels AstraZeneca on biotech company acquisition ICLG.com

DATROWAY® (datopotamab deruxtecan-dlnk) approved in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer AstraZeneca US

Nxera Pharma appoints AstraZeneca alum as inaugural commercial chief Fierce Pharma

Erin Andrews teams up with AstraZeneca on "Get Body Checked Against Cancer" campaign Oncodaily

$220M Deal: FibroGen Divests China Operations to AstraZeneca, Extends Cash Runway to 2028 Stock Titan

AstraZeneca Makes Potential $1B Cell Therapy Play in EsoBiotec Buy BioSpace

AstraZeneca boosts China presence with FibroGen's anemia drug in $160 million deal Yahoo Finance

AstraZeneca Reaches $51 Million Settlement in Pay-for-Delay Suit Bloomberg Law News